Arthritis and Musculoskeletal Alliance
Influencing policy and care together for best lifelong musculoskeletal health
Hope on the horizon for immuno-suppressed/compromised individuals
The National Rheumatoid Arthritis Society, in partnership with ARMA, delivered a Facebook live session on vaccination and new COVID-19 treatments aimed at anyone who is immunosuppressed.
Watch the recording to learn about a new scheme to rapidly get treatments to those who are immunocompromised and a trial of treatments for those over 50 or with certain risk factors.
We all look forward to 2022 with some trepidation. We don’t know how much impact Omicron will have on the NHS, the population, and our own families. 2021 was a year of challenge and also of incredible achievements. A vaccination programme which has now provided all adults with the opportunity for three doses, four in some cases; which has delivered boosters to three quarters of the eligible population; which delivered 1.6 million boosters in the final week of the year. None of this just happened.…
Read more of this article
Final update on the James Lind Alliance Psoriatic Arthritis Priority Setting Partnership
During the last two years the researchers running the James Lind Alliance Priority Setting Partnership have explored unmet needs in psoriatic arthritis, determining what is important for people living with psoriatic arthritis, their families and carers, and the healthcare professionals treating them. The project is now complete.
The results from this project will be used to guide future research. This infographic [opens in PDF] summarizes the project and its findings.…
Read more of this article
The application period for the third edition of the Brain Mind Pain Grant (2021-2022) started on 30 November 2021 and runs until the end of March 2022.
The BMP Grant aims to support projects that will help improve the quality of life of people living with brain, mind, and pain conditions. The theme of the third edition of the BMP Grant is prevention and self-management. It has been decided to narrow the focus to ‘Healthy Sleep for People Living with Brain, Mind and Pain Conditions’.…
Read more of this article
Psychosocial risks and work-related musculoskeletal disorders: exploring the links and prevention strategies
A new report explores the connections between psychosocial factors and musculoskeletal disorders (MSDs) in the workplace using data from the latest European Working Conditions Survey and European Survey of Enterprises on New and Emerging Risks.
It finds that some psychosocial factors — such as working time, job security and support from management — have more of an impact on MSDs than factors related to socio-demographics, country or economic sector.…
Read more of this article
ARMA is pleased to welcome new associate member AbbVie to its membership.
AbbVie is a research-based biopharmaceutical company discovering and delivering transformational medicines and products in several key therapeutic areas such as immunology. AbbVie invests in research to discover, develop and deliver new medicines. They target diseases with significant unmet need where we can improve the standard of care with innovative new therapies. They aim to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.…
Read more of this article
NOA Webinar: COVID Orthopaedic Recovery: National and International recruitment
16 February 2022 at 1pm
The first National Orthopaedic Alliance webinar for 2022 will look at national and international recruitment.
Probably the biggest issue impeding orthopaedic surgery recovery is staffing. Many members of staff have left the NHS, retired early or have long term medical and/or mental health issues that limit their ability to work.
This has resulted in staffing shortages across various orthopaedic services in particular, theatre staffing. Providers are desperate to retain staff but also want to recruit the best people for the job which sometimes means looking overseas.…
Read more of this article
The Nuffield Foundation, in partnership with Versus Arthritis, has announced £4 million for new research funding to improve the social and economic wellbeing of people living with musculoskeletal conditions in the UK. Applicants should develop interdisciplinary proposals that can help identify, develop and enhance non-clinical policy and practice interventions.
The deadline for outline applications is 14 March 2022.
Find out more and apply via the Nuffield Foundation website.
The All Party Parliamentary Group (APPG) for Osteoporosis and Bone Health published a report into the long-standing postcode lottery in the NHS for osteoporosis care. The report highlights the scale of under-diagnosis, under-treatment and missed opportunities in the NHS, with a blueprint for change. Implementation of the blueprint in England and Wales could save the NHS around £287m over five years – a return on investment of around 3:1 – according to the Royal Osteoporosis Society (ROS), which has supported the Inquiry.…
Read more of this article
PCRMM webinar: National Early Inflammatory Arthritis Audit (NEIAA)
18 January 2022, 7 – 8.30pm
PCRMM is delighted to have the Audit’s Clinical Director, Dr Jo Ledingham, opening the Society’s 2022 series of webinars with this extremely interesting talk about the background of the national early inflammatory arthritis audit (NEIAA).
Dr Ledingham will be justifying the need for and the potential benefits of the Audit; she will clarify what it is looking at and why, offering insights into latest performance and on how data can be used for QI activity.…
Read more of this article
